SK
Sridhar Kumar Dodda
About Sridhar Kumar Dodda
Data last updated:
Sridhar Kumar Dodda has 20 years in corporate governance. Holds Director role. Currently with 1 company, including Nucleus Drugs Private Limited and Glaxco Pharmaceuticals Private Limited. Formerly with 3 companies, such as Dainty Laboratories Private Limited and P.R. Drugs Private Limited. Engaged in General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
 Glaxco Pharmaceuticals Private Limited U51900TG2020PTC142378 | Director | 15 Nov 2021 | 2020 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
 Dainty Laboratories Private Limited U24233TG2013PTC090821 | Director | 17 Feb 2014 | 2013 | Strike Off |
| P.R. Drugs Private Limited U24111KA1990PTC010978 | Additional Director | 28 Nov 2012 | 1990 | Active |
| Nucleus Drugs Private Limited U24230TG2005PTC048507 | Director | 21 Dec 2005 | 2005 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sridhar Kumar Dodda
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sridhar Kumar Dodda
Sridhar Kumar Dodda has 20 years in corporate governance. Holds Director role. Currently with 1 company, including Nucleus Drugs Private Limited and Glaxco Pharmaceuticals Private Limited. Formerly with 3 companies, such as Dainty Laboratories Private Limited and P.R. Drugs Private Limited. Engaged in General Business. Contributes to corporate operations.
Sridhar Kumar Dodda is associated with 1 company as Director.
Sridhar Kumar Dodda has expertise in General Business.
Sridhar Kumar Dodda has 20 years in corporate governance.